Health Care Roundup: Drug Companies Are Happy, Consumers Are Screwed

Was I too tough on President Trump yesterday? After all, his new Medicare policy on pharmaceuticals will lower prices if he follows through with it. But will he? And will it really make much of a difference even if he does?

Well, there’s one group of experts who don’t seem too worried: Wall Street investors. Here’s how the stock market reacted over the past few days:

On Wednesday, when the White House announced Trump’s speech, investors were nervous and pharmaceutical stocks dropped. But on Thursday they started hearing soothing rumors, and a little after 2 pm they heard the speech itself. Pharmaceutical stocks spiked up as everyone realized that nothing bad was happening. Then they drifted down a bit until the market closed and drifted up after the opening bell today.

None of these movements were huge. But that’s the point: it’s pretty obvious that investors and analysts aren’t very worried about things. They simply don’t believe that Trump’s new Medicare policy is going to have much effect on either sales or profits in the pharmaceutical industry.

And while we’re on the subject of Trump and health care, check this out:

The complete analysis from the Kaiser Family Foundation is here. If Trump had left everything alone, silver-level premiums would have dropped about 16 percent this year. But because of his deliberate efforts to try to ruin Obamacare, premiums will remain about the same. More than likely, this means Trump has failed: despite his best efforts, he hasn’t done enough to have a serious impact on the overall use of Obamacare. “Staying the same” doesn’t give him much of a hook to claim that Obamacare is failing,¹ and he’s obviously lost the fight over pre-existing conditions. This severely limits what he and Republicans can do in the future.

¹Not that he won’t try. And in fairness, this gives liberals a tough PR message too. People don’t get mad at premiums staying the same no matter how much you tell them that without Trump they probably would have gone down.

Fact:

In-depth journalism that investigates the powerful takes real money and is so damn important right now.But it doesn’t take a Mother Jones investigation to know that billionaires and corporations will never fund the type of reporting (like they do politicians) we do that exists to help bring about change. Instead, our mission-driven journalism is made possible by people power, and has been for 46 years now since our founding as a non-profit.

In “TITLE TK” Monica Bauerlein writes about the perilous moment we’re in, and why it’s so important that we raise $325,000 by the time November’s midterms are decided so we can be ready to throw everything we have at the big issues facing the nation no matter what happens. Please help MoJo’s people-powered journalism with a donation today.

$400,000 to go!

payment methods

Fact:

In-depth journalism that investigates the powerful takes real money and is so damn important right now.But it doesn’t take a Mother Jones investigation to know that billionaires and corporations will never fund the type of reporting (like they do politicians) we do that exists to help bring about change. Instead, our mission-driven journalism is made possible by people power, and has been for 46 years now since our founding as a non-profit.

In “TITLE TK” Monica Bauerlein writes about the perilous moment we’re in, and why it’s so important that we raise $325,000 by the time November’s midterms are decided so we can be ready to throw everything we have at the big issues facing the nation no matter what happens. Please help MoJo’s people-powered journalism with a donation today.

$400,000 to go!

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate